Tags

Type your tag names separated by a space and hit enter

Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men.

Abstract

BACKGROUND

Sugar-sweetened beverage consumption is associated with weight gain and risk of type 2 diabetes mellitus. Few studies have tested for a relationship with coronary heart disease (CHD) or intermediate biomarkers. The role of artificially sweetened beverages is also unclear.

METHODS AND RESULTS

We performed an analysis of the Health Professionals Follow-Up Study, a prospective cohort study including 42 883 men. Associations of cumulatively averaged sugar-sweetened (eg, sodas) and artificially sweetened (eg, diet sodas) beverage intake with incident fatal and nonfatal CHD (myocardial infarction) were examined with proportional hazard models. There were 3683 CHD cases over 22 years of follow-up. Participants in the top quartile of sugar-sweetened beverage intake had a 20% higher relative risk of CHD than those in the bottom quartile (relative risk=1.20; 95% confidence interval, 1.09-1.33; P for trend <0.01) after adjustment for age, smoking, physical activity, alcohol, multivitamins, family history, diet quality, energy intake, body mass index, pre-enrollment weight change, and dieting. Artificially sweetened beverage consumption was not significantly associated with CHD (multivariate relative risk=1.02; 95% confidence interval, 0.93-1.12; P for trend=0.28). Adjustment for self-reported high cholesterol, high triglycerides, high blood pressure, and diagnosed type 2 diabetes mellitus slightly attenuated these associations. Intake of sugar-sweetened but not artificially sweetened beverages was significantly associated with increased plasma triglycerides, C-reactive protein, interleukin-6, and tumor necrosis factor receptors 1 and 2 and decreased high-density lipoprotein, lipoprotein(a), and leptin (P<0.02).

CONCLUSIONS

Consumption of sugar-sweetened beverages was associated with increased risk of CHD and some adverse changes in lipids, inflammatory factors, and leptin. Artificially sweetened beverage intake was not associated with CHD risk or biomarkers.

Links

  • PMC Free PDF
  • PMC Free Full Text
  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115, USA.

    , , , ,

    Source

    Circulation 125:14 2012 Apr 10 pg 1735-41, S1

    MeSH

    Adult
    Aged
    Beverages
    Biomarkers
    Cohort Studies
    Coronary Disease
    Diabetes Mellitus, Type 2
    Humans
    Male
    Middle Aged
    Proportional Hazards Models
    Prospective Studies
    Risk
    Sweetening Agents

    Pub Type(s)

    Journal Article
    Research Support, N.I.H., Extramural
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    22412070

    Citation

    de Koning, Lawrence, et al. "Sweetened Beverage Consumption, Incident Coronary Heart Disease, and Biomarkers of Risk in Men." Circulation, vol. 125, no. 14, 2012, pp. 1735-41, S1.
    de Koning L, Malik VS, Kellogg MD, et al. Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation. 2012;125(14):1735-41, S1.
    de Koning, L., Malik, V. S., Kellogg, M. D., Rimm, E. B., Willett, W. C., & Hu, F. B. (2012). Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation, 125(14), pp. 1735-41, S1. doi:10.1161/CIRCULATIONAHA.111.067017.
    de Koning L, et al. Sweetened Beverage Consumption, Incident Coronary Heart Disease, and Biomarkers of Risk in Men. Circulation. 2012 Apr 10;125(14):1735-41, S1. PubMed PMID: 22412070.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. AU - de Koning,Lawrence, AU - Malik,Vasanti S, AU - Kellogg,Mark D, AU - Rimm,Eric B, AU - Willett,Walter C, AU - Hu,Frank B, Y1 - 2012/03/12/ PY - 2012/3/14/entrez PY - 2012/3/14/pubmed PY - 2012/6/12/medline SP - 1735-41, S1 JF - Circulation JO - Circulation VL - 125 IS - 14 N2 - BACKGROUND: Sugar-sweetened beverage consumption is associated with weight gain and risk of type 2 diabetes mellitus. Few studies have tested for a relationship with coronary heart disease (CHD) or intermediate biomarkers. The role of artificially sweetened beverages is also unclear. METHODS AND RESULTS: We performed an analysis of the Health Professionals Follow-Up Study, a prospective cohort study including 42 883 men. Associations of cumulatively averaged sugar-sweetened (eg, sodas) and artificially sweetened (eg, diet sodas) beverage intake with incident fatal and nonfatal CHD (myocardial infarction) were examined with proportional hazard models. There were 3683 CHD cases over 22 years of follow-up. Participants in the top quartile of sugar-sweetened beverage intake had a 20% higher relative risk of CHD than those in the bottom quartile (relative risk=1.20; 95% confidence interval, 1.09-1.33; P for trend <0.01) after adjustment for age, smoking, physical activity, alcohol, multivitamins, family history, diet quality, energy intake, body mass index, pre-enrollment weight change, and dieting. Artificially sweetened beverage consumption was not significantly associated with CHD (multivariate relative risk=1.02; 95% confidence interval, 0.93-1.12; P for trend=0.28). Adjustment for self-reported high cholesterol, high triglycerides, high blood pressure, and diagnosed type 2 diabetes mellitus slightly attenuated these associations. Intake of sugar-sweetened but not artificially sweetened beverages was significantly associated with increased plasma triglycerides, C-reactive protein, interleukin-6, and tumor necrosis factor receptors 1 and 2 and decreased high-density lipoprotein, lipoprotein(a), and leptin (P<0.02). CONCLUSIONS: Consumption of sugar-sweetened beverages was associated with increased risk of CHD and some adverse changes in lipids, inflammatory factors, and leptin. Artificially sweetened beverage intake was not associated with CHD risk or biomarkers. SN - 1524-4539 UR - https://www.unboundmedicine.com/medline/citation/22412070/full_citation L2 - http://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.111.067017?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -